社区MMT门诊服药者HCV感染及其肝纤维化的影响因素分析
发布时间：2018-10-22 14:18
【摘要】：目的了解社区美沙酮维持治疗(MMT)门诊服药人员丙型肝炎病毒(HCV)的感染状况,以及感染者肝纤维化的进展程度,并分析其影响因素。方法 2016年8-9月在云南和甘肃5所MMT门诊,收集服药人员的HCV感染状况,并招募部分抗-HCV阳性者进行横断面研究,收集血样,计算APRI和FIB4以评估其肝纤维化程度,并调查其人口学特征、行为习惯、治疗情况以及艾滋病病毒(HIV)/HCV合并感染状况等。结果 5所MMT门诊在治人数合计2 343例,抗-HCV阳性868例(37.0%),HIV抗体阳性150例(6.4%),HIV/HCV合并感染138例(5.9%)。招募390例抗-HCV阳性服药人员为研究对象。其中103例(占26.4%)为肝纤维化程度F2期以上,57例为F4期,占14.6%。接受HCV抗病毒治疗者占13.3%(52/390)。采用HCV标准抗病毒治疗者中,用干扰素或长效干扰素者26例,用干扰素或长效干扰素联合利巴韦林的22例,用小分子药物的4例。多因素Logistic回归分析结果显示,饮酒2~4次/周[比值比(OR)=2.2,95%可信区间CI:1.2~4.2]、吸毒时间≥30年(OR=7.3,95%CI:1.4~37.5)、合并HIV感染(OR=0.4,95%CI:0.2~0.7)是肝纤维化进展的影响因素。结论 MMT门诊服药人员HCV感染率较高,实际接受HCV标准抗病毒治疗的比例偏低。饮酒、吸毒时间、合并HIV感染对肝纤维化的进展程度有重要的影响,应加强门诊工作人员的能力建设,使之能更好地对HCV感染者提供宣传教育、咨询及治疗服务。
[Abstract]:Objective to investigate the status of hepatitis C virus (HCV) infection and the progression of hepatic fibrosis in community methadone maintenance therapy (MMT) outpatients, and to analyze the influencing factors. Methods from August to September 2016, five MMT outpatient clinics in Yunnan and Gansu were selected to collect HCV infection status of drug users, and some anti-HCV positive patients were recruited for cross-sectional study, blood samples were collected, and APRI and FIB4 were calculated to evaluate the degree of hepatic fibrosis. The demographic characteristics, behavioral habits, treatment and HIV / HCV co-infection were investigated. Results there were 2 343 cases in 5 MMT outpatient clinics, 868 cases (37. 0%) were positive for anti-HCV (6. 4%), 138 cases (5. 9%) were complicated with HIV/HCV infection. A total of 390 anti-HCV positive drug users were recruited. Among them, 103 cases (26.4%) had liver fibrosis above F2 stage, 57 cases were F4 stage, accounting for 14.6%. 13. 3% (52 / 390) received HCV antiviral therapy. 26 cases were treated with interferon or long-acting interferon, 22 cases were treated with interferon or long-acting interferon combined with ribavirin, and 4 cases were treated with small molecule drugs. The results of multivariate Logistic regression analysis showed that drinking 2 times / week [ratio of (OR) = 2.2% 95% confidence interval CI:1.2~4.2], drug use time 鈮，
本文编号：2287399
[Abstract]:Objective to investigate the status of hepatitis C virus (HCV) infection and the progression of hepatic fibrosis in community methadone maintenance therapy (MMT) outpatients, and to analyze the influencing factors. Methods from August to September 2016, five MMT outpatient clinics in Yunnan and Gansu were selected to collect HCV infection status of drug users, and some anti-HCV positive patients were recruited for cross-sectional study, blood samples were collected, and APRI and FIB4 were calculated to evaluate the degree of hepatic fibrosis. The demographic characteristics, behavioral habits, treatment and HIV / HCV co-infection were investigated. Results there were 2 343 cases in 5 MMT outpatient clinics, 868 cases (37. 0%) were positive for anti-HCV (6. 4%), 138 cases (5. 9%) were complicated with HIV/HCV infection. A total of 390 anti-HCV positive drug users were recruited. Among them, 103 cases (26.4%) had liver fibrosis above F2 stage, 57 cases were F4 stage, accounting for 14.6%. 13. 3% (52 / 390) received HCV antiviral therapy. 26 cases were treated with interferon or long-acting interferon, 22 cases were treated with interferon or long-acting interferon combined with ribavirin, and 4 cases were treated with small molecule drugs. The results of multivariate Logistic regression analysis showed that drinking 2 times / week [ratio of (OR) = 2.2% 95% confidence interval CI:1.2~4.2], drug use time 鈮，
本文编号：2287399
本文链接：https://www.wllwen.com/yixuelunwen/xiaohjib/2287399.html
最近更新
教材专著
